The VALIDATE Network - Vaccine development for complex intracellular neglected pathogens
Search

Funded Directors' Fund Projects

In 2025, VALIDATE made 7 Directors' Fund awards of up to £5,000 each for innovative project ideas by our members. You can find out about this call on the Directors' Fund page.

 

 

Susana Flores Villalva

Vaccines Across Species: understanding mechanisms, importance, and shared benefits under a One Health approach

Dr Susana Flores Villalva, Instituto Nacional de Investigaciones Forestales Agrícolas y Pecuarias (INIFAP), Mexico
Shuailin Li

Employing a high-throughput screening platform to identify epitopes recognised by mycobacteria-reactive TCRs that expand in the lung mucosa following aerosol BCG challenge

Dr Shuailin Li, University of Oxford, UK
Suventha Moodley

Understanding Upper-airway Pathobiont Colonization and Risk Factors in Paediatric Tuberculosis (UPLIFT-TB)

Dr Suventha Moodley, Stellenbosch University, South Africa
Stephen Muhi

M. ulcerans challenge agent clinical-grade manufacture

Dr Stephen Muhi, University of Melbourne & Royal Melbourne Hospital, Australia
Cristian Segura-Cerda

LINE: Vaccines Around the City

Dr Cristian Alfredo Segura-Cerda, Centro de Investigación y Asistencia en Tecnología y Diseño de Jalisco (CIATEJ) & Secretariat of Science, Humanities, Technology and Innovation (SECIHTI), Mexico
Oluwaseun Taofeek

Assessing the feasibility, acceptability, and implementation strategies for novel TB vaccines among adolescents and adults in Nigeria

Mr Oluwaseun Taofeek, Helix Biogen Institute, Nigeria
Andy Tran

Design and development of an open-source ELISpot reader enabled by 3D printing

Dr Andy Tran, City St George's, University of London (SGUL), United Kingdom (UK)